Aria Pharmaceuticals

About Aria Pharmaceuticals

Aria Pharmaceuticals utilizes artificial intelligence to accelerate drug discovery and development processes in the biopharmaceutical sector. The company focuses on identifying novel therapeutic targets and optimizing candidate selection, reducing time and costs associated with bringing new drugs to market.

Aria Pharmaceuticals utilizes artificial intelligence to accelerate drug discovery and development processes in the biopharmaceutical sector. The company focuses on identifying novel therapeutic targets and optimizing candidate selection, reducing time and costs associated with bringing new drugs to market.

What does Aria Pharmaceuticals do?

Aria Pharmaceuticals utilizes artificial intelligence to accelerate drug discovery and development processes in the biopharmaceutical sector. The company focuses on identifying novel therapeutic targets and optimizing candidate selection, reducing time and costs associated with bringing new drugs to market.

When was Aria Pharmaceuticals founded?

Aria Pharmaceuticals was founded in 2014.

Founded
2014
Employees
5 employees
Investors
Aria EmikoOup
AP

Aria Pharmaceuticals

Aria Pharmaceuticals utilizes artificial intelligence to accelerate drug discovery and development processes in the biopharmaceutical sector. The company focuses on identifying novel therapeutic targets and optimizing candidate selection, reducing time and costs associated with bringing new drugs to market.

Founded 201453K+ followers5/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • Aria Pharmaceuticals utilizes artificial intelligence to accelerate drug discovery and development processes in the biopharmaceutical sector. The company focuses on identifying novel therapeutic targets and optimizing candidate selection, reducing time and costs associated with bringing new drugs to market.
This profile is AI-generated and may contain inaccuracies.